Skip to content

A clinical trials for treatment of premature ventricular contractions by integrated Traditional and Western Medicine

A clinical trials for treatment of premature ventricular contractions by integrated traditional and Western Medicine

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12002794
Enrollment
Unknown
Registered
2012-12-08
Start date
2011-08-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

premature ventricular contractions

Interventions

Trial Group I:Dingxin Recipe
Trial Group II:both Dingxin Recipe and amiodarone

Sponsors

School of Traditional Chinese Medicine; Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to 84 Years

Inclusion criteria

Inclusion criteria: 1. the Lown classification of premature ventricular contractions at 2-4A; 2. meeting the diagnostic criteria of TCM for palpitations; 3. unlimited to gender,age from 35 years old to 65 years old; 4. subjects voluntarily sign informed consent.

Exclusion criteria

Exclusion criteria: 1. patients with other heart diseases and other system diseases (such as anemia, hyperthyroidism) and unknown cause to premature ventricular contractions; 2. acute myocardial infarction within 3 months; 3. the Lown classification of premature ventricular contractions above 4B and other malignant arrhythmia; 4. patients also with severe primary brain, liver, kidney and hematopoietic system diseases and heart function at IV grade; 5. patients with hypertension at 3 level or a high risk of hypertension; 6. psychiatric patients, or patients with excessive drinking or smoking; 7. taking related to the anti-arrhythmia medicine within two weeks of Chinese medicine, Western medicine less than 5 half-life; 8. Recruiters had participated in other clinical trials 4 weeks before this study; 9. pregnant women or lactating women; 10. needed to treat of other serious system diseases; * belongs amiodarone contraindications (severe sinus node dysfunction, II, or III degree of AV block, bradycardia, QT interval prolongation, allergic to this product)

Design outcomes

Primary

MeasureTime frame
The effectiveness of premature ventricular contract;

Secondary

MeasureTime frame
the effect of TCM syndrome;Heart rate variability analysis;

Countries

China

Contacts

Public ContactYuhua Jia
jyh@fimmu.com+86 13660593381

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026